Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|November 6, 2002
Hereditary multiple exostoses and heparan sulfate polymerizationBeverly M Zak, Brett E Crawford, Jeffrey D Esko
Critical Reviews in Biochemistry and Molecular Biology|December 11, 2007
Glycan antagonists and inhibitors: a fount for drug discoveryJillian R Brown, Brett E Crawford, Jeffrey D Esko
Infection and Immunity|August 23, 2005
Cell surface heparan sulfate promotes replication of Toxoplasma gondiiJoseph R Bishop, Brett E Crawford, Jeffrey D Esko
The Journal of Biological Chemistry|February 22, 2007
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathwayLev Elson-Schwab, Omai B Garner, Manuela Schuksz, et al.
Disease Markers|February 12, 2013
WITHDRAWN: Glycan-based biomarkers for mucopolysaccharidosesRoger Lawrence, Jillian R Brown, Fred Lorey, et al.
Molecular Genetics and Metabolism|August 21, 2013
Glycan-based biomarkers for mucopolysaccharidosesRoger Lawrence, Jillian R Brown, Fred Lorey, et al.
The Journal of Biological Chemistry|October 13, 2012
N-sulfation of heparan sulfate regulates early branching events in the developing mammary glandKevin T Bush, Brett E Crawford, Omai B Garner, et al.
Plos One|May 27, 2010
Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in miceBrett E Crawford, Omai B Garner, Joseph R Bishop, et al.
Nature Chemical Biology|January 11, 2012
Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidosesRoger Lawrence, Jillian R Brown, Kanar Al-Mafraji, et al.
Glycobiology|January 4, 2020
Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVARoger Lawrence, Heather Prill, Preejith P Vachali, et al.
Pageof 4